BioMarin Pharmaceutical Stock Shows Rising Relative Strength

BioMarin Pharmaceutical (BMRN) stock had its Relative Strength (RS) Rating upgraded from 70 to 77 Thursday -- a welcome improvement, but still short of the 80 or better score you look for. X When looking for the best stocks to buy and watch, keep a close on eye on relative price strength. This…

#bmrn #relativestrength #rs #medicalbiomedbiotech #amphastarpharm #amph